Melanoma Institute Australia – Leica, the manufacturer of the state-of-the-art Bond RX stainer, has generously agreed to discoun...
Part of monitoring a patient’s response to treatment involves running tests on stained tissue biopsies. Our current slide stainer is 19 years old and like most old technology has limitations. Faster, more in-depth test results could serve our patients better. Our clinicians desperately need a new slide stainer!
Leica, the manufacturer of the state-of-the-art Bond RX stainer, has generously agreed to discount the cost, but we still need $175,000 to purchase this equipment.
Today is #GivingTuesday, a global day dedicated to generosity. Before the day ends, we're asking for our community to make a donation to help the incredible researchers and clinicians at Melanoma Institute Australia to achieve the best possible outcome for our patients.
Donate now and help change lives: http://bit.ly/MIAupgrade